ACOPF(ACOPF)
ACOPF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $2.18B | $2.37B | $2.64B | $2.87B |
| Low | $2.00B | $2.18B | $2.43B | $2.64B |
| High | $2.27B | $2.47B | $2.76B | $3.00B |
| EBITDA Avg | $486M | $529M | $590M | $642M |
| Low | $447M | $487M | $543M | $590M |
| High | $508M | $552M | $616M | $670M |
| EBIT Avg | $439M | $477M | $532M | $579M |
| Low | $403M | $439M | $489M | $532M |
| High | $458M | $498M | $556M | $604M |
| Net Income Avg | $241M | $297M | $364M | $372M |
| Low | $216M | $266M | $326M | $333M |
| High | $255M | $313M | $385M | $394M |
| EPS Avg | $0.33 | $0.41 | $0.50 | $0.51 |
| Low | $0.30 | $0.36 | $0.45 | $0.46 |
| High | $0.35 | $0.43 | $0.53 | $0.54 |
| Analysts (Rev / EPS) | 13 / 1 | 5 / 1 | 9 / 1 | 12 / 1 |